Access cutting-edge multifocal motor neuropathy treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access multifocal motor neuropathy specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multifocal motor neuropathy treatment provided free
The main purpose of this study is to compare empasiprubart and IVIg in adult patients with MMN. The study consists of a double-blinded part A (empasiprubart, IVIg) and an open-label part B (empasiprubart). The maximum study duration for participants is up to 49 months.
Sponsor: argenx
Check if you qualify for this multifocal motor neuropathy clinical trial in San Francisco, CA
If you're searching for multifocal motor neuropathy treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multifocal motor neuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.